Associated Papers
Mendelian Susceptibility to Mycobacterial Disease with Signal Peptide Peptidase-like 2A (SPPL2A) Deficiency: A Case Report.
Esmaeilzadeh H et al.
Iranian Journal of Allergy, Asthma, and Immunology, 2024
Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review.
Khavandegar A et al.
The Journal of Allergy and Clinical Immunology, 2024
Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.
Errami A et al.
Journal of Clinical Immunology, 2023
An updated review on Mendelian susceptibility to mycobacterial diseases- a silver jubilee celebration of its first genetic diagnosis.
Das J et al.
Expert Review of Clinical Immunology, 2021
Mendelian susceptibility to mycobacterial disease: recent discoveries.
Bustamante J
Human Genetics, 2020
Mendelian susceptibility to mycobacterial disease: 2014-2018 update.
Rosain J et al.
Immunology and Cell Biology, 2019
Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency.
Kong XF et al.
Nature Immunology, 2018
Select a paper to view details